Other Issues:
previous
|
next
|
latest
|
archive
Volume 5(Suppl 4); 2003
Introduction
New Perspectives on Benign Prostatic Hyperplasia
Herbert Lepor
Rev Urol.
2003;
5
(Suppl 4)
: S1–S2.
PMCID:
PMC1502350
|
Full Text
|
PDF–51K
|
New Perspectives on BPH
Clinical Evaluation of Benign Prostatic Hyperplasia
Kevin T McVary
Rev Urol.
2003;
5
(Suppl 4)
: S3–S11.
PMCID:
PMC1502354
|
Abstract
|
Full Text
|
PDF–115K
|
Benign Prostatic Hyperplasia: Does Prostate Size Matter?
J. Curtis Nickel
Rev Urol.
2003;
5
(Suppl 4)
: S12–S17.
PMCID:
PMC1502356
|
Abstract
|
Full Text
|
PDF–132K
|
5-α-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia
Claus G Roehrborn
Rev Urol.
2003;
5
(Suppl 4)
: S18–S27.
PMCID:
PMC1502355
|
Abstract
|
Full Text
|
PDF–171K
|
Long-Term Experience with 5-α-Reductase Inhibitors
E. Darracott Vaughan, Jr
Rev Urol.
2003;
5
(Suppl 4)
: S28–S33.
PMCID:
PMC1502352
|
Abstract
|
Full Text
|
PDF–89K
|
Landmark Studies Impacting the Medical Management of Benign Prostatic Hyperplasia
Herbert Lepor
Rev Urol.
2003;
5
(Suppl 4)
: S34–S41.
PMCID:
PMC1502353
|
Abstract
|
Full Text
|
PDF–130K
|
The Medical Therapy of Prostatic Symptoms Study: What Will We Learn?
Kevin M Slawin
Rev Urol.
2003;
5
(Suppl 4)
: S42–S47.
PMCID:
PMC1502351
|
Abstract
|
Full Text
|
PDF–78K
|
Benign Prostatic Hyperplasia: Case Scenarios
J. Curtis Nickel
Rev Urol.
2003;
5
(Suppl 4)
: S48–S49.
PMCID:
PMC1502357
|
Full Text
|
PDF–54K
|
Other Issues:
previous
|
next
|
latest
|
archive
